Publications

Below are highlighted the recent publications of the last several years. To find a full list of the collaborative efforts of Dr. Eric Johannsen in recent years as well as his past publications, perform a PubMed search for Dr. Eric Johannsen’s publications.

This is an accordion element with a series of buttons that open and close related content panels.

Principle Investigator

Host Interactions:

  • Epstein-Barr Virus Induces Host Shutoff extensively via BGLF5-independent mechanisms. PMID: 39298313
  • EBV Reactivation from Latency Is a Degrading Experience for the Host. PMID: 36992435
  • Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes. PMID: 33720992

Lytic Reactivation:

  • Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription. PMID: 36174106
  • An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle. PMID: 30700606

EBV transcriptomics:

  • Accurate Quantification of Overlapping Herpesvirus Transcripts from RNA Sequencing Data. PMID: 34705568
  • CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. PMID: 29864140

Other:

  • Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle. PMID: 31431547
  • Pharmcards – Review Cards for Medical Students, 5th edition. ISBN-13: 978-1496384287

Collaborations

Gumperz Lab (UW-Madison):

  • Human CD4(+) iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma. PMID: 38736328

Kenney Lab (UW-Madison):

  • Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ. PMID: 37155846
  • Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes. PMID: 36190982
  • Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells. PMID: 35472072
  • ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells. PMID: 34748616
  • Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. PMID: 34339458
  • EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. PMID: 32542010
  • An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model. PMID: 32132242
  • B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection. PMID: 32059024
  • An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PMID: 30125329
  • A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PMID: 30052684
  • Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. PMID: 28179525
  • Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. PMID: 28003489

Mertz Lab (UW-Madison):

  • Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PMID: 28617871

Luftig Lab (Duke):

  • Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection. PMID: 28425914